Curon Biopharmaceutical
PrivateLast Round
M&A
Oct 1, 2024
Est. Valuation
$214M
Total Funding Raised
$250M
Company Overview
Curon Biopharmaceutical is a biotechnology company that develops innovative cancer immunotherapies, including bispecific antibodies and antibody-drug conjugates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curon Biopharmaceutical Comparables
Compare Curon Biopharmaceutical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cullinan Oncology | 80% | |
| Gilead Sciences | 78% | |
| EpimAb Biotherapeutics | 78% | |
Curon Biopharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 1, 2024 | ||||
| Series B | Dec 28, 2019 | ||||
| Series A | Jul 27, 2018 |
Curon Biopharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series B |
| Boyu Capital | Series A |
| Temasek | Series A |
| Oriza Holdings | Series B |
| Hillhouse Investment | Series B |
| Shengshan Asset Management | Series B |
| Lilly Asia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2024
Grew 67% QoQ, from 6 to 10 employees.
Curon Biopharmaceutical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curon Biopharmaceutical's valuation, stock price, and market status.